Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.

Procedural entryThis page is a short order in Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.. Read the opinion of the Court — 678 F.3d 1280
Court of Appeals for the Federal Circuit·Decided June 13, 2012·No. 2011-1126·Published

Opinion

United States Court of Appeals for the Federal Circuit ______________________

June 13, 2012

ERRATUM ______________________

Appeal Nos. 2011-1126, -1127

OTSUKA PHARMACEUTICAL CO., LTD.,

Plaintiff-Appellee,

v.

SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON BV, SYNTHON HOLDINGS BV, SYNTHON LABORATORIES, INC., and SYNTHON PHARMACEUTICALS, INC.,

Defendants,

and

APOTEX INC. and APOTEX CORP.,

Defendants-Appellants,

and TEVA PHARMACEUTICALS USA, INC., BARR LABORATORIES, INC., and BARR PHARMACEUTICALS, INC.,

Defendants-Appellants.

Decided: May 7, 2012 Precedential Opinion ______________________

The following change has been made:

Page 21, line 4, “marketed” has been changed to -- promising--.

Free access — add to your briefcase to read the full text and ask questions with AI

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc., (Fed. Cir. 2012).

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc. (Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.